Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Clinical presentation and outcome in primary familial hypomagnesaemia

Clinical presentation and outcome in primary familial hypomagnesaemia The clinical presentation and long term outcome (mean follow up eight years, range 0.25 to 21) of 15 patients with autosomal recessive primary familial hypomagnesaemia is described. The most common (67%) presenting events were generalised hypocalcaemic-hypomagnesaemic seizures at a mean (SD) age of 4.9 (2.5) weeks. Thirteen infants, treated soon after diagnosis with high dose enteral magnesium developed normally. Their serum calcium returned to normal concentrations but serum magnesium could not be maintained at normal concentrations (0.53 (0.12 SD) mmol/l; normal >0.62). Delay in establishing a diagnosis led to a convulsive disorder with permanent neurological impairment in two infants. Reported complications of prolonged hypomagnesaemia such as renal stones, hypertension, arrhythmias, sudden death, or dyslipidaemia were not observed. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Disease in Childhood British Medical Journal

Clinical presentation and outcome in primary familial hypomagnesaemia

Download PDF

Clinical presentation and outcome in primary familial hypomagnesaemia

Shalev, Hanna; Phillip, Moshe; Galil, Aharon; Carmi, Rivka; Landau, Daniel
Archives of Disease in Childhood , Volume 78 (2) – Feb 1, 1998

Abstract


The clinical presentation and long term outcome (mean follow up eight years, range 0.25 to 21) of 15 patients with autosomal recessive primary familial hypomagnesaemia is described. The most common (67%) presenting events were generalised hypocalcaemic-hypomagnesaemic seizures at a mean (SD) age of 4.9 (2.5) weeks. Thirteen infants, treated soon after diagnosis with high dose enteral magnesium developed normally. Their serum calcium returned to normal concentrations but serum magnesium could not be maintained at normal concentrations (0.53 (0.12 SD) mmol/l; normal >0.62). Delay in establishing a diagnosis led to a convulsive disorder with permanent neurological impairment in two infants. Reported complications of prolonged hypomagnesaemia such as renal stones, hypertension, arrhythmias, sudden death, or dyslipidaemia were not observed.

Loading next page...
 
/lp/british-medical-journal/clinical-presentation-and-outcome-in-primary-familial-hypomagnesaemia-X8k66HHkJN

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
British Medical Journal
Copyright
Royal College of Paediatrics and Child Health
ISSN
0003-9888
eISSN
1468-2044
DOI
10.1136/adc.78.2.127
Publisher site
See Article on Publisher Site

Abstract

The clinical presentation and long term outcome (mean follow up eight years, range 0.25 to 21) of 15 patients with autosomal recessive primary familial hypomagnesaemia is described. The most common (67%) presenting events were generalised hypocalcaemic-hypomagnesaemic seizures at a mean (SD) age of 4.9 (2.5) weeks. Thirteen infants, treated soon after diagnosis with high dose enteral magnesium developed normally. Their serum calcium returned to normal concentrations but serum magnesium could not be maintained at normal concentrations (0.53 (0.12 SD) mmol/l; normal >0.62). Delay in establishing a diagnosis led to a convulsive disorder with permanent neurological impairment in two infants. Reported complications of prolonged hypomagnesaemia such as renal stones, hypertension, arrhythmias, sudden death, or dyslipidaemia were not observed.

Journal

Archives of Disease in Childhood – British Medical Journal

Published: Feb 1, 1998

Keywords: hypomagnesaemia hypocalcaemia genetics tetany

References

  • Chronic hypomagnesemia with magnesium-depended hypocalcemia. I. A new syndrome with intestinal magnesium malabsorption.
  • Studies in primary hypomagnesaemia: evidence for defective carrier-mediated small intestinal transport of magnesium.
  • Primary hypomagnesemia with secondary hypocalcemia. Report of a case and review of the world literature.
  • Primary hypomagnesaemia. A case report and literature review.
  • Primary infantile hypomagnesaemia: report of two cases and review of literature.
  • Primary hypomagnesaemia: a case report.
  • Effect of magnesium on blood pressure.
  • Torsade de pointes and magnesium deficiency.
  • Magnesium and lipids in cardiovascular disease.
  • Effect of a chronic suboptimal intake of magnesium on magnesium and calcium content of bone and on bone strength of the rat.
  • Abnormal renal magnesium handling.
  • Parathyroid hormone secretion and resposiveness to parathyroid hormone in primary hypomagnesemia.
  • Evaluation of lumbar bone mineral density by dual energy x-ray absorptiometry.
  • Magnesium metabolism in childhood.
  • Magnesium requirements in human nutrition.
  • Magnesium metabolism in renal stone disease.
  • Familial hypomagnesemia—a follow up examination of three patients after 9 to 12 years of treatment.
  • Congenital primer hypomagnesemia, an inborn error of metabolism.
  • Tetany due to hypomagnesemia with secondary hypocalcemia.
  • Hypocalcemie magnesodependante par trouble specifique de l’absorption du magnesium associee a une anomalie chromosomique.
  • Hypomagnesemia with secondary hypocalcemia in a female with balanced X/9 translocation: mapping of the Xp22 chromosome breakpoint.
  • Primaere hypomagneseiaemie. Klinischer verlauf, diagnostische und therapeutische untersuchungen bei drei kinder.
  • Primary hypomagnesemia, an autosomal recessive inherited disease?
  • Les defiecits magnesien de l’enfants.
  • Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of balanced translocation breakpoint.
  • Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.
  • Impaired release of parathyroid hormone in magnesium deficiency.
  • Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25 dihydroxyvitamin D metabolism.
  • Hypomagnesemic hypocalcemia independent of parathyroid hormone.
  • Idiopathic hypoparathyroidism presenting as dementia.
  • Congenital hypomagnesemia: alternative to tissue biopsies for monitoring body magnesium status.
  • Familial hypokalemia-hypomagnesemia (Gitelman’s syndrome).
  • Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.